Q3 2016

Filed Dec 5, 2016 · 10-Q · 66 days after period end · 0001121781-16-000585

Q3 2016 · 10-Q

Revenue

$95.00K

+1,087.5% vs Q3 2015

Net Income

-$211.00K

N/M vs Q3 2015

EPS Diluted

-$1.36

N/M vs Q3 2015

Gross Profit$10,000N/M

Operating Income

Same quarter

Metric	Q3 2016	Q3 2015	Q3 2014	Q3 2013
Revenue	$95.00K	$8.00K	$22.00K	$86.00K
Net Income	-$211.00K	-$2.19M	-$2.97M	-$1.44M
EPS Diluted	-$1.36	-$1.75	-$0.04	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR